Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.
about
Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1Cardiovascular abnormalities in autosomal-dominant polycystic kidney diseaseA spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)The functions of TRPP2 in the vascular systemMutations of the human polycystic kidney disease 2 (PKD2) geneUrinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric studyThe influence of renal manifestations to the progression of autosomal dominant polycystic kidney diseaseIdentification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study.p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levelsThe use of ultrasonography and linkage studies for early diagnosis of autosomal dominant polycystic kidney disease (ADPKD).The HALT polycystic kidney disease trials: design and implementation.Determinants of renal disease variability in ADPKD.Hypertension in autosomal dominant polycystic kidney disease.A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark.Predictors of autosomal dominant polycystic kidney disease progressionKidney: polycystic kidney disease.ADPKD: Prototype of Cardiorenal Syndrome Type 4Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease.A young patient with a family history of hypertension.Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney diseaseVariation in age at ESRD in autosomal dominant polycystic kidney diseaseEffect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participantsRenal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.Blood pressure in early autosomal dominant polycystic kidney disease.Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patientsIdentification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approachGlomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.Nephrotic syndrome and autosomal dominant polycystic kidney disease.Molecular pathways and therapies in autosomal-dominant polycystic kidney diseasePulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trialRefining the localization of the PKD2 locus on chromosome 4q by linkage analysis in Spanish families with autosomal dominant polycystic kidney disease type 2.Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney diseaseComparative Study of Outcomes among Patients with Polycystic Kidney Disease on Hemodialysis and Peritoneal Dialysis.Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease2-Hydroxyestradiol slows progression of experimental polycystic kidney disease
P2860
Q24299323-D2E69F6D-94A0-4D70-9CCA-3252A6BC334EQ24657714-C8CCBF8E-7A50-484D-A8C4-F56439C497FDQ24678335-C56EAAD0-40D4-4A19-B6C2-F003767941D2Q26771361-5E898B21-705D-4C5C-9837-2810E95671D6Q28204836-D371B923-C966-4E2A-A53B-1FA19F2D8E5EQ28484968-7B2F0A3D-5A0D-4F94-BDD3-CCB44C9CE4A4Q30485303-089F0060-3096-4BE8-8FCB-542E64897FCEQ30870783-C16A8404-71EC-4ED0-B8BB-2BF99C7273EFQ33294928-6B665B24-E658-469F-AA90-E7288EA4B719Q33536798-A4E59C68-A629-4FE8-A3EF-19A04AD01177Q33571347-01926C98-1E35-4DE5-BE6C-4D915772C41BQ33723857-788ACB75-CC8B-4C45-9096-F0441B84005DQ33754691-3637D861-53D7-4E7D-B647-27009632678AQ33770038-3119638C-A4F5-4A18-B2D2-C99E703CE85AQ33868896-E5F8205D-919C-4939-8E50-028C533E79B5Q34194508-BCB21C7C-B19D-4361-93D5-CCE5DB13A926Q34405449-02398598-F4AF-40BF-995C-3FBE2A26E7DFQ34427678-D87D018D-7E4C-4567-90E0-BE0603F055F4Q34436755-474F97C7-5E70-4B3C-A364-A3707315F6FDQ34475590-C99B0E12-CBF0-4DA8-B0AA-43EAC6E62A1FQ34538347-3B05CB72-1EF9-44C9-A1D8-E6CA6D103935Q34629700-331B3D02-9B80-4D3D-9C34-EEBD154A3E56Q34639667-4D056CBD-FF32-4DB5-9554-F57A2C88C80DQ34740084-54512458-51A1-4EB8-BCD5-812AA8241494Q34796003-97E291CD-7D86-40D5-B739-AE318276FD73Q34978995-66AB0F8F-6BCA-4622-BC7F-9C13EFCB033DQ35129320-973CC94B-CD60-4584-BC26-DCCFD1AD36E8Q35167862-F29E2DCE-413A-4B6B-A0CD-13415C416FEAQ35250423-6FE1BFB8-58D0-4B66-8533-D2993E763009Q35267170-F9E2FDB8-BC96-4787-8CA5-D29238E8CC5BQ35453142-318D9D62-0FDF-4F6C-848C-467708608106Q35578646-1B3A529E-172E-47E4-9419-21EE6346F12BQ35579142-D0089E10-A32C-4DCE-BBF2-FFABF5B325A7Q35643863-24C58CC5-BF27-4377-80BB-DEDDD6452DE1Q35661408-48908069-ED13-47BE-9EC6-B8CC098465EAQ35777393-7D7DA26F-6BCB-4405-8AEA-2E81EA00F3C0Q35812435-72A1E070-4F02-411F-BBB3-887525BA66BCQ35922036-CCE12FB0-E990-4E94-9D3B-FDAF7180BB9FQ35923086-FC40C63B-DCE4-42F0-9C45-197487EB410AQ35964504-C98B00D2-70E3-446D-95D5-7C2512B5F417
P2860
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Factors affecting the progress ...... ant polycystic kidney disease.
@en
Factors affecting the progress ...... ant polycystic kidney disease.
@nl
type
label
Factors affecting the progress ...... ant polycystic kidney disease.
@en
Factors affecting the progress ...... ant polycystic kidney disease.
@nl
prefLabel
Factors affecting the progress ...... ant polycystic kidney disease.
@en
Factors affecting the progress ...... ant polycystic kidney disease.
@nl
P2093
P356
P1433
P1476
Factors affecting the progress ...... ant polycystic kidney disease.
@en
P2093
Johnson AM
Kimberling WJ
Lezotte DC
P2888
P304
P356
10.1038/KI.1992.195
P407
P577
1992-05-01T00:00:00Z